Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joris R de Groot

Showing results (171-180 of 184) with videos related to

Pageof 19
Sort By:
European Heart Journal. Quality of Care & Clinical Outcomes|September 1, 2025
Effects of anticoagulation in patients with device-detected atrial fibrillation and multiple stroke risk factors: a win ratio analysis of the NOAH-AFNET 6 trialNina Becher, Gina Köllner, Emanuele Bertaglia, et al.
Journal of the American Heart Association|August 27, 2024
Anticoagulation in Patients With Device-Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: The NOAH-AFNET 6 TrialHans Christoph Diener, Nina Becher, Susanne Sehner, et al.
The New England Journal of Medicine|August 25, 2023
Anticoagulation with Edoxaban in Patients with Atrial High-Rate EpisodesPaulus Kirchhof, Tobias Toennis, Andreas Goette, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 30, 2024
Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS)Andreas Goette, Domenico Corradi, Dobromir Dobrev, et al.
European Heart Journal|November 13, 2023
Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 hNina Becher, Tobias Toennis, Emanuele Bertaglia, et al.
Circulation. Arrhythmia and Electrophysiology|September 30, 2025
Dual Epicardial and Endocardial Procedure (DEEP) for Persistent or Longstanding Persistent Atrial FibrillationKenneth A Ellenbogen, Ali Khoynezhad, Mark La Meir, et al.
European Heart Journal Open|June 12, 2026
Design and rationale of the RISC-trial: multicentre <i>R</i>CT to assess <i>i</i>mmediate discharge of <i>s</i>yncope patients admitted to the (<i>c</i>ardiac) emergency roomThomas T Boel, Suzanne Y G Peeters, Anouk P van Alem, et al.
The New England Journal of Medicine|August 7, 2020
Subcutaneous or Transvenous Defibrillator TherapyReinoud E Knops, Louise R A Olde Nordkamp, Peter-Paul H M Delnoy, et al.
BMJ Open|August 27, 2020
Design and rationale of DUTCH-AF: a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillationGordon Chu, Jaap Seelig, Emmy M Trinks-Roerdink, et al.
Circulation|April 25, 2025
Device-related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-term Follow-up: the PRAETORIAN-XL TrialLouise R A Olde Nordkamp, Jolien A de Veld, Abdul Ghani, et al.
Pageof 19

Showing results (171-180 of 184) with videos related to

Sort By:
Pageof 19
European Heart Journal. Quality of Care & Clinical Outcomes|September 1, 2025
Effects of anticoagulation in patients with device-detected atrial fibrillation and multiple stroke risk factors: a win ratio analysis of the NOAH-AFNET 6 trialNina Becher, Gina Köllner, Emanuele Bertaglia, et al.
Journal of the American Heart Association|August 27, 2024
Anticoagulation in Patients With Device-Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: The NOAH-AFNET 6 TrialHans Christoph Diener, Nina Becher, Susanne Sehner, et al.
The New England Journal of Medicine|August 25, 2023
Anticoagulation with Edoxaban in Patients with Atrial High-Rate EpisodesPaulus Kirchhof, Tobias Toennis, Andreas Goette, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 30, 2024
Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS)Andreas Goette, Domenico Corradi, Dobromir Dobrev, et al.
European Heart Journal|November 13, 2023
Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 hNina Becher, Tobias Toennis, Emanuele Bertaglia, et al.
Circulation. Arrhythmia and Electrophysiology|September 30, 2025
Dual Epicardial and Endocardial Procedure (DEEP) for Persistent or Longstanding Persistent Atrial FibrillationKenneth A Ellenbogen, Ali Khoynezhad, Mark La Meir, et al.
European Heart Journal Open|June 12, 2026
Design and rationale of the RISC-trial: multicentre <i>R</i>CT to assess <i>i</i>mmediate discharge of <i>s</i>yncope patients admitted to the (<i>c</i>ardiac) emergency roomThomas T Boel, Suzanne Y G Peeters, Anouk P van Alem, et al.
The New England Journal of Medicine|August 7, 2020
Subcutaneous or Transvenous Defibrillator TherapyReinoud E Knops, Louise R A Olde Nordkamp, Peter-Paul H M Delnoy, et al.
BMJ Open|August 27, 2020
Design and rationale of DUTCH-AF: a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillationGordon Chu, Jaap Seelig, Emmy M Trinks-Roerdink, et al.
Circulation|April 25, 2025
Device-related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-term Follow-up: the PRAETORIAN-XL TrialLouise R A Olde Nordkamp, Jolien A de Veld, Abdul Ghani, et al.
Pageof 19